Web29 nov. 2024 · In connection with the proposed business combination (the "Business Combination") between HealthCor Catalio Acquisition Corp. (the "HealthCor"), … Web25 mrt. 2024 · subsidiary of HealthCor (“Merger Sub II”), Hyperfine, Inc., a Delaware corporation (“Legacy Hyperfine”), and Liminal Sciences, Inc., a Delaware corporation (“Liminal”). On December 22, 2024, immediately upon the consummation of the Business Combination, ... Legacy Hyperfine and Liminal, as the case may be. 3.
Juyi Li - Senior Regulatory Affairs Specialist - Medtronic LinkedIn
WebWarning: Cannot modify header information - headers already sent by (output started at /home1/mhmhosting/public_html/4seasonsheatnair.com/wp-config.php:7) in /home1 ... WebIn July 2024, Hyperfine and Liminal Sciences will go public by merging with a SPAC called HealthCor Catalio Acquisition Corp. The merger is valued at approximately USD 580 million upon closing. Through the deal, HealthCor Catalio will be renamed as Hyperfine and will be listed on the NASDAQ stock exchange under the ticker symbol HYPR. health care in america articles
Hyperfine Closes Business Combination
WebHyperfine Announces Receipt of Additional $3.3 Million Grant to Improve Access to Neonatal and Pediatric Brain Imaging in Low-Resource Settings Globally -… WebHyperfine, Inc., Creator of the First FDA-Cleared Portable MRI Device, and Liminal Sciences, Inc. To Be Listed on Nasdaq Through a Business Combination With HealthCor Catalio Acquisition Corp. WebConnor helped put together the deals to bring Butterfly Network, Quantum-Si, Hyperfine, and Liminal Sciences to the public markets – resulting in over $1.25B of gross proceeds. Separately, Connor helped finance and build out the business models for some of the earlier-stage 4Catalyzer companies. Dr. Jonathan Rothberg Co-founder Scientific Advisor golf wang fashion show bathrobe